26.79USD0.00%Mkt Cap: 1.43B USDP/E: —Last update: 2026-05-26
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kal…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap1.43B USD
Enterprise Value1.42B USD
Revenue (TTM)114.48M USD
Gross Profit58.47M USD
Net Income (TTM)-183.44M USD
Revenue/Share2.110 USD
Last Price26.79 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees275
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4834971032
Valuation
P/E (Trailing)—
P/E (Forward)22.37
PEG—
EV/EBITDA-10.29
EV/Revenue12.44
P/S12.45
P/B-505.09
EPS (TTM)-3.94
EPS (Forward)1.20
52W Range
9.830100% of range26.85
52W High26.85 USD
52W Low9.830 USD
Profitability
Gross Margin51.07%
Oper. Margin-57.37%
EBITDA Margin-120.94%
Profit Margin-118.74%
ROE6766.65%
ROA-54.70%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-152.91M USD
CapEx (TTM)929.00K USD
FCF Margin—
FCF Yield—
Net Debt-718.02K USD
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity-55.91
Current Ratio5.17
Quick Ratio4.97
Book Value/Sh-0.0530 USD
Cash/Share5.354 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 22, 2016
Splits
Last Split1:14
Split DateNov 22, 2016
Analyst Consensus
Rating2.7 (Hold)
Target (Mean)28.60 USD
Target Range27.00 USD – 35.00 USD
# Analysts5
Ownership
Shares Out.53.24M
Float33.25M
Insiders1.66%
Institutions137.23%
Short Interest
Short Ratio3.2d
Short % Float31.89%
Short % Out.28.52%
Shares Short15.16M
Short (prev mo.)20.36M
Technical
SMA 5021.49 (+24.7%)
SMA 20015.93 (+68.2%)
Beta-0.12
S&P 52W Chg28.31%
Avg Vol (30d)5.41M
Avg Vol (10d)3.84M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—